CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $6.84 | $24K | 36,218 |
| 2026-07-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $7.80 | $27K | 39,718 |
| 2026-07-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −400 | $84.37 | $34K | 39,318 |
| 2026-07-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −2,497 | $85.86 | $214K | 36,821 |
| 2026-07-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −3,803 | $86.68 | $330K | 33,018 |
| 2026-07-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −300 | $87.25 | $26K | 32,718 |
| 2026-07-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,500 | 200,563 | ||
| 2026-07-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −3,500 | 171,992 | ||
| 2026-07-13 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +8,541 | $12.50 | $107K | 23,853 |
| 2026-07-13 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +1,458 | $34.39 | $50K | 25,311 |
| 2026-07-13 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −300 | $83.07 | $25K | 25,011 |
| 2026-07-13 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −3,743 | $84.26 | $315K | 21,268 |
| 2026-07-13 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −5,656 | $84.90 | $480K | 15,612 |
| 2026-07-13 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −300 | $85.63 | $26K | 15,312 |
| 2026-07-13 | Agarwal Arjun Senior Vice President, Finance | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −8,541 | 101,459 | ||
| 2026-07-13 | Agarwal Arjun Senior Vice President, Finance | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,458 | 61,250 | ||
| 2026-07-01 | Fairmount Funds Management LLC Director | Conversion | +3,553,410 | 4,685,364 | ||
| 2026-07-01 | Fairmount Funds Management LLC Director | Sale | −3,553,410 | $84.43 | $300.0M | 1,131,954 |
| 2026-07-01 | Fairmount Funds Management LLC Director | Conversion · Series B Preferred Stock | −42,641 | 94,497 | ||
| 2026-07-01 | Sandler Laura Lee Chief Operating Officer | Option exercise 10b5-1 | +5,000 | $7.80 | $39K | 241,384 |
Page 7 of 18 · 346 trades